# Treatment Duration on Normobaric Hyperoxia in Acute Ischemic Stroke

> **NCT05404373** · NA · COMPLETED · sponsor: **Capital Medical University** · enrollment: 100 (actual)

## Conditions studied

- Stroke, Acute
- Neuroprotection
- Endovascular Treatment

## Interventions

- **OTHER:** Normobaric Hyperoxia (NBO)
- **OTHER:** Low flow oxygen

## Key facts

- **NCT ID:** NCT05404373
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-20
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05404373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05404373, "Treatment Duration on Normobaric Hyperoxia in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05404373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*